New lung cancer treatment shows promise by targeting resistant tumors in stage 3 NSCLC, offering hope for patients who don’t respond to standard therapies.

Meet the service dog that helped a woman survive multiple cancers before launching a film career. Onyx is a Goldendoodle and a source of comfort.

Researchers test direct tumor injections to improve responses to chemoradiation in lung cancer patients, according to a new CONVERGE trial.

A recent study led by researchers at Stanford Medicine has discovered a potential link between the seizure medication Keppra (levetiracetam) and extended.

Imfinzi plus chemo improves survival rates for gastric cancer patients, according to the MATTERHORN trial results.

Girl shares her leukemia treatment experience and journey with cancer diagnosis.

Enhertu HER2 lung cancer trial shows longer progression‑free survival than Keytruda plus chemo, giving new hope for patients with advanced disease.

Home workouts became a lifeline for a breast cancer survivor, rebuilding strength and reclaiming independence through Patti’s Palace garage gym.

Only 19.5% of Medicare Part D cancer drug appeals succeeded between 2020-2024—discover why patients overlook this lifesaving option and how to improve approval

Join a mother's ovarian cancer awareness campaign, her tenth year advocating to save daughters from this silent threat.